NCT02282098View on ClinicalTrials.gov

Colchicine in Atrial Fibrillation to Prevent Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 17, 2020

Study Completion Date

November 17, 2020

Conditions
Atrial FibrillationStroke
Interventions
DRUG

Colchicine

Colchicine 0.6mg twice daily

DRUG

Placebo

Placebo Colchicine

Trial Locations (1)

L8L 2X2

Hamilton General Hospital, Hamilton

Sponsors
All Listed Sponsors
lead

Population Health Research Institute

OTHER

NCT02282098 - Colchicine in Atrial Fibrillation to Prevent Stroke | Biotech Hunter | Biotech Hunter